logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Aureobasidin A CAS 127785-64-2

Aureobasidin A CAS 127785-64-2

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 127785-64-2

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
127785-64-2
Appearance::
White To Beige Powder
Molecular Formula::
C60H92N8O11
Molecular Weight::
1101.42000
EINECS NO::
NA
MDL NO::
NA
CAS NO::
127785-64-2
Appearance::
White To Beige Powder
Molecular Formula::
C60H92N8O11
Molecular Weight::
1101.42000
EINECS NO::
NA
MDL NO::
NA
Aureobasidin A CAS 127785-64-2

 

Product Description:

Product Name: Aureobasidin A CAS NO: 127785-64-2

 

 

Synonyms:

Cyclo[L-Phe-N-methyl-L-Phe-L-Pro-L-aIle-N-methyl-L-Val-L-Leu-N-methyl-β-hydroxy-L-Val-[(3R)-D-Hmp-]-N-methyl-L-Val-];

LY-295337;

Aureobasidin A (9CI);

 

 

Chemical & Physical Properties:

Appearance: White to beige Powder

Assay :≥99.0%

Density: 1.19g/cm3

Boiling Point: 1229.1℃ at 760 mmHg

Flash Point: 697.1℃

Refractive Index: 1.574

Vapor Pressure: 0mmHg at 25℃

 

 

Aureobasidin A is a cyclic depsipeptide that is produced byfermentation in cultures of Aureobasidium pullulan.Aureobasidin A acts as a tight-binding noncompetitive inhibitorof the enzyme inositol phosphorylceramide synthase(IPC synthase), which is an essential enzyme for fungalsphingolipid biosynthesis. A unique structural feature of theaureobasidins is the N-methylation of four of seven amide nitrogenatoms. The lack of tautomerism dictated by N-methylationmay contribute to forming a stable solution conformerthat is shaped somewhat like an arrowhead, the presumed biologicallyactive conformation of aureobasidin-A.The pradimycins and benanomycins are naphthacenequinonesthat bind mannan in the presence of Ca2+ to disrupt the cell membrane in pathogenic fungi. Both demonstrate good in vitro and in vivo activity againstCandida spp. and C. neoformans clinical isolates.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.